C12Q 2521/519
Topoisomerase
C12Q2521/519 (Topoisomerase) appears on 3 US grants and 7 published applications in this corpus.
Search patents in C12Q- Granted patents
- 3
- Published applications
- 7
- Assignees
- 5
- Inventors
- 12
- Latest grant
- 3 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 2 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Method of amplifying circular DNA3 Dec 2024US 12,157,915 B2Moderna Enzymatics Co., Ltd.
- Topoisomerase inhibitor for mimicking the effect of ionizing radiations on T cells27 Aug 2024US 12,070,470 B2Novagray
- Methods and compositions for modulation of bacterial topoisomerase enzymes16 Jan 2001US 6,174,678 B1Small Molecule Therapeutics, Inc.
- Method of Amplifying Circular DNA6 Feb 2025US 2025/0043341 A1Moderna Enzymatics Co., Ltd.
- Systems and methods for clonal replication and amplification of nucleic acid molecules for genomic and therapeutic applications7 Nov 2024US 2024/0368682 A1
- A topoisomerase inhibitor for mimicking the effect of ionizing radiations on t cells22 Jul 2021US 2021/0220381 A1Novagray
- Method of amplifying circular dna12 Sep 2019US 2019/0276883 A1Moderna Enzymatics Co., Ltd.
- Systems and methods for clonal replication and amplification of nucleic acid molecules for genomic and therapeutic applications9 Mar 2017US 2017/0067097 A1RedVault Biosciences, LP
Most cited
By later US patents